Chemokines and Their Receptors in Central Nervous System Disease

Author(s): Knut Biber, Eiko K. de Jong, Hilmar R.J. van Weering, Hendrikus W.G.M. Boddeke

Journal Name: Current Drug Targets

Volume 7 , Issue 1 , 2006


Become EABM
Become Reviewer
Call for Editor

Abstract:

Almost a decade ago, it was discovered that the human deficiency virus (HIV) makes use of chemokine receptors to infect blood cells. This appreciation of the clinical relevance of specific chemokine receptors has initiated a considerable boost in the field of chemokine research. It is clear today that chemokine signaling orchestrates the immune system and is widely involved in both physiological and pathophysiological processes. Since the chemokine system offers various targets through which pathology could be influenced, most pharmaceutical companies have chosen this system as a therapeutic target for a variety of diseases. Here recent developments concerning the role of chemokines in diseases of the central nervous system (CNS) as well as their possible therapeutic relevance are discussed.

Keywords: astrocytes, microglia, Hippocampal neurons, AIDS, ICAM-1, ischemic cell death

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 1
Year: 2006
Page: [29 - 46]
Pages: 18
DOI: 10.2174/138945006775270196

Article Metrics

PDF: 31